nodes	percent_of_prediction	percent_of_DWPC	metapath
Procarbazine—brain cancer—peripheral nervous system neoplasm	0.267	1	CtDrD
Procarbazine—Alkylating Activity—Melphalan—peripheral nervous system neoplasm	0.24	0.556	CiPCiCtD
Procarbazine—Alkylating Activity—Dacarbazine—peripheral nervous system neoplasm	0.192	0.444	CiPCiCtD
Procarbazine—Ibuprofen—Melphalan—peripheral nervous system neoplasm	0.145	1	CrCrCtD
Procarbazine—XDH—Cisplatin—peripheral nervous system neoplasm	0.0479	0.473	CbGbCtD
Procarbazine—XDH—Doxorubicin—peripheral nervous system neoplasm	0.0321	0.317	CbGbCtD
Procarbazine—CYP1B1—Doxorubicin—peripheral nervous system neoplasm	0.0213	0.211	CbGbCtD
Procarbazine—XDH—Effects of Nitric Oxide—MB—peripheral nervous system neoplasm	0.00137	0.752	CbGpPWpGaD
Procarbazine—Atenolol—ABCB1—peripheral nervous system neoplasm	0.00018	0.692	CrCbGaD
Procarbazine—XDH—Nucleotide metabolism—NME1—peripheral nervous system neoplasm	0.000127	0.0698	CbGpPWpGaD
Procarbazine—Ibuprofen—ABCB1—peripheral nervous system neoplasm	8.06e-05	0.309	CrCbGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—NF1—peripheral nervous system neoplasm	7.88e-05	0.0432	CbGpPWpGaD
Procarbazine—Constipation—Alitretinoin—peripheral nervous system neoplasm	3.3e-05	0.000625	CcSEcCtD
Procarbazine—Purpura—Doxorubicin—peripheral nervous system neoplasm	3.3e-05	0.000625	CcSEcCtD
Procarbazine—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	3.29e-05	0.000623	CcSEcCtD
Procarbazine—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	3.29e-05	0.000623	CcSEcCtD
Procarbazine—Oedema—Cisplatin—peripheral nervous system neoplasm	3.29e-05	0.000623	CcSEcCtD
Procarbazine—Infection—Cisplatin—peripheral nervous system neoplasm	3.27e-05	0.000619	CcSEcCtD
Procarbazine—Vomiting—Topotecan—peripheral nervous system neoplasm	3.26e-05	0.000618	CcSEcCtD
Procarbazine—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	3.25e-05	0.000615	CcSEcCtD
Procarbazine—Lethargy—Doxorubicin—peripheral nervous system neoplasm	3.25e-05	0.000615	CcSEcCtD
Procarbazine—Vomiting—Tretinoin—peripheral nervous system neoplasm	3.24e-05	0.000613	CcSEcCtD
Procarbazine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	3.24e-05	0.000613	CcSEcCtD
Procarbazine—Rash—Topotecan—peripheral nervous system neoplasm	3.24e-05	0.000613	CcSEcCtD
Procarbazine—Dermatitis—Topotecan—peripheral nervous system neoplasm	3.23e-05	0.000613	CcSEcCtD
Procarbazine—Decreased appetite—Vincristine—peripheral nervous system neoplasm	3.23e-05	0.000612	CcSEcCtD
Procarbazine—Ataxia—Epirubicin—peripheral nervous system neoplasm	3.23e-05	0.000612	CcSEcCtD
Procarbazine—Cough—Etoposide—peripheral nervous system neoplasm	3.22e-05	0.00061	CcSEcCtD
Procarbazine—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	3.22e-05	0.00061	CcSEcCtD
Procarbazine—Headache—Topotecan—peripheral nervous system neoplasm	3.22e-05	0.000609	CcSEcCtD
Procarbazine—Rash—Tretinoin—peripheral nervous system neoplasm	3.21e-05	0.000608	CcSEcCtD
Procarbazine—Rash—Isotretinoin—peripheral nervous system neoplasm	3.21e-05	0.000608	CcSEcCtD
Procarbazine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	3.21e-05	0.000608	CcSEcCtD
Procarbazine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	3.21e-05	0.000608	CcSEcCtD
Procarbazine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	3.21e-05	0.000608	CcSEcCtD
Procarbazine—Fatigue—Vincristine—peripheral nervous system neoplasm	3.21e-05	0.000607	CcSEcCtD
Procarbazine—Convulsion—Etoposide—peripheral nervous system neoplasm	3.2e-05	0.000606	CcSEcCtD
Procarbazine—Vomiting—Melphalan—peripheral nervous system neoplasm	3.2e-05	0.000605	CcSEcCtD
Procarbazine—Headache—Tretinoin—peripheral nervous system neoplasm	3.19e-05	0.000604	CcSEcCtD
Procarbazine—Headache—Isotretinoin—peripheral nervous system neoplasm	3.19e-05	0.000604	CcSEcCtD
Procarbazine—Hypertension—Etoposide—peripheral nervous system neoplasm	3.19e-05	0.000604	CcSEcCtD
Procarbazine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	3.18e-05	0.000603	CcSEcCtD
Procarbazine—Constipation—Vincristine—peripheral nervous system neoplasm	3.18e-05	0.000602	CcSEcCtD
Procarbazine—Pain—Vincristine—peripheral nervous system neoplasm	3.18e-05	0.000602	CcSEcCtD
Procarbazine—Diplopia—Doxorubicin—peripheral nervous system neoplasm	3.18e-05	0.000602	CcSEcCtD
Procarbazine—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	3.18e-05	0.000602	CcSEcCtD
Procarbazine—Rash—Melphalan—peripheral nervous system neoplasm	3.17e-05	0.0006	CcSEcCtD
Procarbazine—Dermatitis—Melphalan—peripheral nervous system neoplasm	3.17e-05	0.0006	CcSEcCtD
Procarbazine—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	3.16e-05	0.000598	CcSEcCtD
Procarbazine—Anorexia—Cisplatin—peripheral nervous system neoplasm	3.14e-05	0.000594	CcSEcCtD
Procarbazine—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	3.09e-05	0.000586	CcSEcCtD
Procarbazine—Hypotension—Cisplatin—peripheral nervous system neoplasm	3.07e-05	0.000582	CcSEcCtD
Procarbazine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	3.07e-05	0.000581	CcSEcCtD
Procarbazine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	3.07e-05	0.000581	CcSEcCtD
Procarbazine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	3.05e-05	0.000578	CcSEcCtD
Procarbazine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	3.05e-05	0.000578	CcSEcCtD
Procarbazine—Nausea—Topotecan—peripheral nervous system neoplasm	3.05e-05	0.000578	CcSEcCtD
Procarbazine—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	3.04e-05	0.000576	CcSEcCtD
Procarbazine—Confusional state—Etoposide—peripheral nervous system neoplasm	3.04e-05	0.000575	CcSEcCtD
Procarbazine—Nausea—Tretinoin—peripheral nervous system neoplasm	3.03e-05	0.000573	CcSEcCtD
Procarbazine—Nausea—Isotretinoin—peripheral nervous system neoplasm	3.03e-05	0.000573	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	3e-05	0.000568	CcSEcCtD
Procarbazine—Infection—Etoposide—peripheral nervous system neoplasm	2.99e-05	0.000567	CcSEcCtD
Procarbazine—Ataxia—Doxorubicin—peripheral nervous system neoplasm	2.99e-05	0.000566	CcSEcCtD
Procarbazine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	2.99e-05	0.000566	CcSEcCtD
Procarbazine—Nausea—Melphalan—peripheral nervous system neoplasm	2.99e-05	0.000566	CcSEcCtD
Procarbazine—Dysphagia—Epirubicin—peripheral nervous system neoplasm	2.97e-05	0.000563	CcSEcCtD
Procarbazine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	2.95e-05	0.000559	CcSEcCtD
Procarbazine—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	2.95e-05	0.000559	CcSEcCtD
Procarbazine—Tachycardia—Etoposide—peripheral nervous system neoplasm	2.94e-05	0.000557	CcSEcCtD
Procarbazine—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	2.94e-05	0.000557	CcSEcCtD
Procarbazine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	2.94e-05	0.000557	CcSEcCtD
Procarbazine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	2.94e-05	0.000557	CcSEcCtD
Procarbazine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	2.91e-05	0.000552	CcSEcCtD
Procarbazine—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	2.91e-05	0.000552	CcSEcCtD
Procarbazine—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	2.89e-05	0.000548	CcSEcCtD
Procarbazine—Anorexia—Etoposide—peripheral nervous system neoplasm	2.87e-05	0.000544	CcSEcCtD
Procarbazine—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	2.86e-05	0.000542	CcSEcCtD
Procarbazine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	2.86e-05	0.000542	CcSEcCtD
Procarbazine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	2.85e-05	0.00054	CcSEcCtD
Procarbazine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	2.84e-05	0.000539	CcSEcCtD
Procarbazine—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	2.82e-05	0.000534	CcSEcCtD
Procarbazine—Hypotension—Etoposide—peripheral nervous system neoplasm	2.82e-05	0.000533	CcSEcCtD
Procarbazine—Pain—Cisplatin—peripheral nervous system neoplasm	2.81e-05	0.000533	CcSEcCtD
Procarbazine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	2.77e-05	0.000525	CcSEcCtD
Procarbazine—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	2.75e-05	0.000521	CcSEcCtD
Procarbazine—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	2.74e-05	0.00052	CcSEcCtD
Procarbazine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	2.74e-05	0.000519	CcSEcCtD
Procarbazine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	2.73e-05	0.000517	CcSEcCtD
Procarbazine—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	2.72e-05	0.000515	CcSEcCtD
Procarbazine—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	2.71e-05	0.000514	CcSEcCtD
Procarbazine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	2.71e-05	0.000513	CcSEcCtD
Procarbazine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	2.71e-05	0.000512	CcSEcCtD
Procarbazine—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	2.69e-05	0.00051	CcSEcCtD
Procarbazine—Somnolence—Etoposide—peripheral nervous system neoplasm	2.68e-05	0.000507	CcSEcCtD
Procarbazine—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	2.68e-05	0.000507	CcSEcCtD
Procarbazine—Asthenia—Vincristine—peripheral nervous system neoplasm	2.67e-05	0.000506	CcSEcCtD
Procarbazine—Pneumonia—Epirubicin—peripheral nervous system neoplasm	2.66e-05	0.000505	CcSEcCtD
Procarbazine—Drowsiness—Epirubicin—peripheral nervous system neoplasm	2.65e-05	0.000502	CcSEcCtD
Procarbazine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	2.65e-05	0.000501	CcSEcCtD
Procarbazine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	2.64e-05	0.0005	CcSEcCtD
Procarbazine—Rash—Dactinomycin—peripheral nervous system neoplasm	2.63e-05	0.000497	CcSEcCtD
Procarbazine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	2.62e-05	0.000496	CcSEcCtD
Procarbazine—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	2.61e-05	0.000494	CcSEcCtD
Procarbazine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	2.6e-05	0.000492	CcSEcCtD
Procarbazine—Fatigue—Etoposide—peripheral nervous system neoplasm	2.6e-05	0.000492	CcSEcCtD
Procarbazine—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	2.6e-05	0.000492	CcSEcCtD
Procarbazine—Jaundice—Epirubicin—peripheral nervous system neoplasm	2.58e-05	0.000489	CcSEcCtD
Procarbazine—Stomatitis—Epirubicin—peripheral nervous system neoplasm	2.58e-05	0.000489	CcSEcCtD
Procarbazine—Constipation—Etoposide—peripheral nervous system neoplasm	2.58e-05	0.000488	CcSEcCtD
Procarbazine—Pain—Etoposide—peripheral nervous system neoplasm	2.58e-05	0.000488	CcSEcCtD
Procarbazine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	2.55e-05	0.000484	CcSEcCtD
Procarbazine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	2.55e-05	0.000482	CcSEcCtD
Procarbazine—Sweating—Epirubicin—peripheral nervous system neoplasm	2.54e-05	0.000481	CcSEcCtD
Procarbazine—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	2.54e-05	0.000481	CcSEcCtD
Procarbazine—Haematuria—Epirubicin—peripheral nervous system neoplasm	2.53e-05	0.000478	CcSEcCtD
Procarbazine—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	2.51e-05	0.000475	CcSEcCtD
Procarbazine—Epistaxis—Epirubicin—peripheral nervous system neoplasm	2.5e-05	0.000473	CcSEcCtD
Procarbazine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	2.48e-05	0.00047	CcSEcCtD
Procarbazine—Nausea—Dactinomycin—peripheral nervous system neoplasm	2.47e-05	0.000468	CcSEcCtD
Procarbazine—XDH—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.47e-05	0.0135	CbGpPWpGaD
Procarbazine—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	2.46e-05	0.000467	CcSEcCtD
Procarbazine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	2.46e-05	0.000467	CcSEcCtD
Procarbazine—Dizziness—Vincristine—peripheral nervous system neoplasm	2.46e-05	0.000466	CcSEcCtD
Procarbazine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	2.45e-05	0.000465	CcSEcCtD
Procarbazine—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	2.45e-05	0.000464	CcSEcCtD
Procarbazine—Rash—Alitretinoin—peripheral nervous system neoplasm	2.43e-05	0.000461	CcSEcCtD
Procarbazine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	2.43e-05	0.000461	CcSEcCtD
Procarbazine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	2.42e-05	0.000459	CcSEcCtD
Procarbazine—Headache—Alitretinoin—peripheral nervous system neoplasm	2.42e-05	0.000458	CcSEcCtD
Procarbazine—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	2.4e-05	0.000455	CcSEcCtD
Procarbazine—Urticaria—Etoposide—peripheral nervous system neoplasm	2.39e-05	0.000453	CcSEcCtD
Procarbazine—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	2.39e-05	0.000453	CcSEcCtD
Procarbazine—Jaundice—Doxorubicin—peripheral nervous system neoplasm	2.39e-05	0.000452	CcSEcCtD
Procarbazine—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	2.39e-05	0.000452	CcSEcCtD
Procarbazine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	2.38e-05	0.000451	CcSEcCtD
Procarbazine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	2.38e-05	0.000451	CcSEcCtD
Procarbazine—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	2.38e-05	0.00045	CcSEcCtD
Procarbazine—Vomiting—Vincristine—peripheral nervous system neoplasm	2.37e-05	0.000448	CcSEcCtD
Procarbazine—Asthenia—Cisplatin—peripheral nervous system neoplasm	2.36e-05	0.000447	CcSEcCtD
Procarbazine—Sweating—Doxorubicin—peripheral nervous system neoplasm	2.35e-05	0.000445	CcSEcCtD
Procarbazine—Rash—Vincristine—peripheral nervous system neoplasm	2.35e-05	0.000444	CcSEcCtD
Procarbazine—Dermatitis—Vincristine—peripheral nervous system neoplasm	2.34e-05	0.000444	CcSEcCtD
Procarbazine—Haematuria—Doxorubicin—peripheral nervous system neoplasm	2.34e-05	0.000443	CcSEcCtD
Procarbazine—Headache—Vincristine—peripheral nervous system neoplasm	2.33e-05	0.000441	CcSEcCtD
Procarbazine—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	2.31e-05	0.000438	CcSEcCtD
Procarbazine—Nausea—Alitretinoin—peripheral nervous system neoplasm	2.29e-05	0.000434	CcSEcCtD
Procarbazine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	2.25e-05	0.000426	CcSEcCtD
Procarbazine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	2.22e-05	0.00042	CcSEcCtD
Procarbazine—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	2.21e-05	0.000419	CcSEcCtD
Procarbazine—Nausea—Vincristine—peripheral nervous system neoplasm	2.21e-05	0.000418	CcSEcCtD
Procarbazine—Flushing—Epirubicin—peripheral nervous system neoplasm	2.21e-05	0.000418	CcSEcCtD
Procarbazine—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	2.2e-05	0.000417	CcSEcCtD
Procarbazine—Asthenia—Etoposide—peripheral nervous system neoplasm	2.16e-05	0.000409	CcSEcCtD
Procarbazine—Chills—Epirubicin—peripheral nervous system neoplasm	2.13e-05	0.000404	CcSEcCtD
Procarbazine—Pruritus—Etoposide—peripheral nervous system neoplasm	2.13e-05	0.000404	CcSEcCtD
Procarbazine—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	2.12e-05	0.000402	CcSEcCtD
Procarbazine—Alopecia—Epirubicin—peripheral nervous system neoplasm	2.1e-05	0.000398	CcSEcCtD
Procarbazine—Vomiting—Cisplatin—peripheral nervous system neoplasm	2.09e-05	0.000396	CcSEcCtD
Procarbazine—Rash—Cisplatin—peripheral nervous system neoplasm	2.07e-05	0.000393	CcSEcCtD
Procarbazine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	2.07e-05	0.000392	CcSEcCtD
Procarbazine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	2.06e-05	0.000391	CcSEcCtD
Procarbazine—Flushing—Doxorubicin—peripheral nervous system neoplasm	2.04e-05	0.000387	CcSEcCtD
Procarbazine—Tension—Epirubicin—peripheral nervous system neoplasm	2.03e-05	0.000385	CcSEcCtD
Procarbazine—Nervousness—Epirubicin—peripheral nervous system neoplasm	2.01e-05	0.000381	CcSEcCtD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	2.01e-05	0.011	CbGpPWpGaD
Procarbazine—Dizziness—Etoposide—peripheral nervous system neoplasm	1.99e-05	0.000377	CcSEcCtD
Procarbazine—Chills—Doxorubicin—peripheral nervous system neoplasm	1.97e-05	0.000374	CcSEcCtD
Procarbazine—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	1.97e-05	0.000372	CcSEcCtD
Procarbazine—Nausea—Cisplatin—peripheral nervous system neoplasm	1.95e-05	0.00037	CcSEcCtD
Procarbazine—Alopecia—Doxorubicin—peripheral nervous system neoplasm	1.94e-05	0.000368	CcSEcCtD
Procarbazine—Vomiting—Etoposide—peripheral nervous system neoplasm	1.92e-05	0.000363	CcSEcCtD
Procarbazine—Anaemia—Epirubicin—peripheral nervous system neoplasm	1.91e-05	0.000362	CcSEcCtD
Procarbazine—Rash—Etoposide—peripheral nervous system neoplasm	1.9e-05	0.00036	CcSEcCtD
Procarbazine—Dermatitis—Etoposide—peripheral nervous system neoplasm	1.9e-05	0.00036	CcSEcCtD
Procarbazine—Headache—Etoposide—peripheral nervous system neoplasm	1.89e-05	0.000358	CcSEcCtD
Procarbazine—Tension—Doxorubicin—peripheral nervous system neoplasm	1.88e-05	0.000356	CcSEcCtD
Procarbazine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	1.86e-05	0.000352	CcSEcCtD
Procarbazine—Syncope—Epirubicin—peripheral nervous system neoplasm	1.86e-05	0.000352	CcSEcCtD
Procarbazine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	1.85e-05	0.000351	CcSEcCtD
Procarbazine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	1.82e-05	0.000345	CcSEcCtD
Procarbazine—Cough—Epirubicin—peripheral nervous system neoplasm	1.81e-05	0.000342	CcSEcCtD
Procarbazine—Convulsion—Epirubicin—peripheral nervous system neoplasm	1.79e-05	0.00034	CcSEcCtD
Procarbazine—Nausea—Etoposide—peripheral nervous system neoplasm	1.79e-05	0.000339	CcSEcCtD
Procarbazine—Hypertension—Epirubicin—peripheral nervous system neoplasm	1.79e-05	0.000338	CcSEcCtD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	1.78e-05	0.00977	CbGpPWpGaD
Procarbazine—Anaemia—Doxorubicin—peripheral nervous system neoplasm	1.77e-05	0.000335	CcSEcCtD
Procarbazine—Arthralgia—Epirubicin—peripheral nervous system neoplasm	1.76e-05	0.000334	CcSEcCtD
Procarbazine—Myalgia—Epirubicin—peripheral nervous system neoplasm	1.76e-05	0.000334	CcSEcCtD
Procarbazine—Anxiety—Epirubicin—peripheral nervous system neoplasm	1.76e-05	0.000333	CcSEcCtD
Procarbazine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	1.72e-05	0.000326	CcSEcCtD
Procarbazine—Syncope—Doxorubicin—peripheral nervous system neoplasm	1.72e-05	0.000325	CcSEcCtD
Procarbazine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	1.71e-05	0.000325	CcSEcCtD
Procarbazine—Confusional state—Epirubicin—peripheral nervous system neoplasm	1.7e-05	0.000323	CcSEcCtD
Procarbazine—Oedema—Epirubicin—peripheral nervous system neoplasm	1.69e-05	0.00032	CcSEcCtD
Procarbazine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	1.68e-05	0.000319	CcSEcCtD
Procarbazine—Infection—Epirubicin—peripheral nervous system neoplasm	1.68e-05	0.000318	CcSEcCtD
Procarbazine—Cough—Doxorubicin—peripheral nervous system neoplasm	1.67e-05	0.000317	CcSEcCtD
Procarbazine—XDH—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.67e-05	0.00915	CbGpPWpGaD
Procarbazine—Shock—Epirubicin—peripheral nervous system neoplasm	1.66e-05	0.000315	CcSEcCtD
Procarbazine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	1.66e-05	0.000314	CcSEcCtD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	1.66e-05	0.0091	CbGpPWpGaD
Procarbazine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	1.65e-05	0.000313	CcSEcCtD
Procarbazine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	1.65e-05	0.000313	CcSEcCtD
Procarbazine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	1.65e-05	0.000312	CcSEcCtD
Procarbazine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	1.63e-05	0.000309	CcSEcCtD
Procarbazine—Myalgia—Doxorubicin—peripheral nervous system neoplasm	1.63e-05	0.000309	CcSEcCtD
Procarbazine—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	1.63e-05	0.000309	CcSEcCtD
Procarbazine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	1.62e-05	0.000308	CcSEcCtD
Procarbazine—Anorexia—Epirubicin—peripheral nervous system neoplasm	1.61e-05	0.000305	CcSEcCtD
Procarbazine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	1.59e-05	0.000302	CcSEcCtD
Procarbazine—Hypotension—Epirubicin—peripheral nervous system neoplasm	1.58e-05	0.000299	CcSEcCtD
Procarbazine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	1.58e-05	0.000298	CcSEcCtD
Procarbazine—Oedema—Doxorubicin—peripheral nervous system neoplasm	1.56e-05	0.000296	CcSEcCtD
Procarbazine—Infection—Doxorubicin—peripheral nervous system neoplasm	1.55e-05	0.000294	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	1.54e-05	0.000291	CcSEcCtD
Procarbazine—Shock—Doxorubicin—peripheral nervous system neoplasm	1.54e-05	0.000291	CcSEcCtD
Procarbazine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	1.53e-05	0.00029	CcSEcCtD
Procarbazine—Insomnia—Epirubicin—peripheral nervous system neoplasm	1.53e-05	0.000289	CcSEcCtD
Procarbazine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	1.53e-05	0.000289	CcSEcCtD
Procarbazine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	1.52e-05	0.000287	CcSEcCtD
Procarbazine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	1.51e-05	0.000286	CcSEcCtD
Procarbazine—Somnolence—Epirubicin—peripheral nervous system neoplasm	1.5e-05	0.000284	CcSEcCtD
Procarbazine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	1.49e-05	0.000282	CcSEcCtD
Procarbazine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	1.47e-05	0.000278	CcSEcCtD
Procarbazine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	1.46e-05	0.000277	CcSEcCtD
Procarbazine—Fatigue—Epirubicin—peripheral nervous system neoplasm	1.46e-05	0.000276	CcSEcCtD
Procarbazine—Constipation—Epirubicin—peripheral nervous system neoplasm	1.44e-05	0.000274	CcSEcCtD
Procarbazine—Pain—Epirubicin—peripheral nervous system neoplasm	1.44e-05	0.000274	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	1.42e-05	0.00027	CcSEcCtD
Procarbazine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	1.41e-05	0.000268	CcSEcCtD
Procarbazine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	1.4e-05	0.000266	CcSEcCtD
Procarbazine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	1.39e-05	0.000264	CcSEcCtD
Procarbazine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	1.39e-05	0.000263	CcSEcCtD
Procarbazine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	1.38e-05	0.000262	CcSEcCtD
Procarbazine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	1.36e-05	0.000257	CcSEcCtD
Procarbazine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	1.35e-05	0.000255	CcSEcCtD
Procarbazine—Urticaria—Epirubicin—peripheral nervous system neoplasm	1.34e-05	0.000254	CcSEcCtD
Procarbazine—Pain—Doxorubicin—peripheral nervous system neoplasm	1.34e-05	0.000253	CcSEcCtD
Procarbazine—Constipation—Doxorubicin—peripheral nervous system neoplasm	1.34e-05	0.000253	CcSEcCtD
Procarbazine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	1.34e-05	0.000253	CcSEcCtD
Procarbazine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	1.34e-05	0.000253	CcSEcCtD
Procarbazine—CYP1B1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.32e-05	0.00726	CbGpPWpGaD
Procarbazine—CYP1B1—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	1.3e-05	0.00715	CbGpPWpGaD
Procarbazine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	1.29e-05	0.000244	CcSEcCtD
Procarbazine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	1.28e-05	0.000242	CcSEcCtD
Procarbazine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	1.24e-05	0.000236	CcSEcCtD
Procarbazine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	1.24e-05	0.000235	CcSEcCtD
Procarbazine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	1.24e-05	0.000234	CcSEcCtD
Procarbazine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	1.24e-05	0.000234	CcSEcCtD
Procarbazine—Asthenia—Epirubicin—peripheral nervous system neoplasm	1.21e-05	0.00023	CcSEcCtD
Procarbazine—XDH—Metabolism—GNS—peripheral nervous system neoplasm	1.21e-05	0.00661	CbGpPWpGaD
Procarbazine—Pruritus—Epirubicin—peripheral nervous system neoplasm	1.2e-05	0.000226	CcSEcCtD
Procarbazine—XDH—Metabolism—NME1—peripheral nervous system neoplasm	1.16e-05	0.00634	CbGpPWpGaD
Procarbazine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	1.16e-05	0.000219	CcSEcCtD
Procarbazine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	1.15e-05	0.000218	CcSEcCtD
Procarbazine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	1.12e-05	0.000212	CcSEcCtD
Procarbazine—Dizziness—Epirubicin—peripheral nervous system neoplasm	1.12e-05	0.000212	CcSEcCtD
Procarbazine—XDH—Metabolism—COX2—peripheral nervous system neoplasm	1.11e-05	0.0061	CbGpPWpGaD
Procarbazine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	1.11e-05	0.000209	CcSEcCtD
Procarbazine—Vomiting—Epirubicin—peripheral nervous system neoplasm	1.07e-05	0.000203	CcSEcCtD
Procarbazine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	1.07e-05	0.000203	CcSEcCtD
Procarbazine—Rash—Epirubicin—peripheral nervous system neoplasm	1.07e-05	0.000202	CcSEcCtD
Procarbazine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	1.06e-05	0.000202	CcSEcCtD
Procarbazine—Headache—Epirubicin—peripheral nervous system neoplasm	1.06e-05	0.0002	CcSEcCtD
Procarbazine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	1.03e-05	0.000196	CcSEcCtD
Procarbazine—Nausea—Epirubicin—peripheral nervous system neoplasm	1e-05	0.00019	CcSEcCtD
Procarbazine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	9.94e-06	0.000188	CcSEcCtD
Procarbazine—Rash—Doxorubicin—peripheral nervous system neoplasm	9.85e-06	0.000187	CcSEcCtD
Procarbazine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	9.85e-06	0.000186	CcSEcCtD
Procarbazine—Headache—Doxorubicin—peripheral nervous system neoplasm	9.79e-06	0.000185	CcSEcCtD
Procarbazine—Nausea—Doxorubicin—peripheral nervous system neoplasm	9.28e-06	0.000176	CcSEcCtD
Procarbazine—CYP1B1—Metabolism—HSD17B12—peripheral nervous system neoplasm	8.93e-06	0.0049	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	7.42e-06	0.00407	CbGpPWpGaD
Procarbazine—XDH—Metabolism—ENO2—peripheral nervous system neoplasm	7.3e-06	0.00401	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—GNS—peripheral nervous system neoplasm	6.46e-06	0.00354	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—NME1—peripheral nervous system neoplasm	6.19e-06	0.0034	CbGpPWpGaD
Procarbazine—XDH—Metabolism—BCHE—peripheral nervous system neoplasm	6.17e-06	0.00339	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—COX2—peripheral nervous system neoplasm	5.96e-06	0.00327	CbGpPWpGaD
Procarbazine—XDH—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.89e-06	0.00323	CbGpPWpGaD
Procarbazine—XDH—Metabolism—TH—peripheral nervous system neoplasm	5.8e-06	0.00318	CbGpPWpGaD
Procarbazine—XDH—Metabolism—GNAS—peripheral nervous system neoplasm	4.74e-06	0.0026	CbGpPWpGaD
Procarbazine—XDH—Metabolism—ABCB1—peripheral nervous system neoplasm	4.65e-06	0.00255	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—ENO2—peripheral nervous system neoplasm	3.91e-06	0.00215	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—BCHE—peripheral nervous system neoplasm	3.31e-06	0.00181	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.15e-06	0.00173	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—TH—peripheral nervous system neoplasm	3.11e-06	0.00171	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—GNAS—peripheral nervous system neoplasm	2.54e-06	0.00139	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—ABCB1—peripheral nervous system neoplasm	2.49e-06	0.00137	CbGpPWpGaD
Procarbazine—XDH—Metabolism—AKT1—peripheral nervous system neoplasm	1.28e-06	0.000701	CbGpPWpGaD
Procarbazine—CYP1B1—Metabolism—AKT1—peripheral nervous system neoplasm	6.85e-07	0.000376	CbGpPWpGaD
